Molecular control of capillary growth in skeletal muscle

Canadian Journal of Applied Physiology

Volumn 27, Issue 5, 2002, Pages 491-515

  Haas, Tara L ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

Endothelium; Growth factors; Matrix metalloproteinases; Muscle stretch; Shear stress

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; MATRIX METALLOPROTEINASE; SIGNAL PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A;

ADAPTATION; ANGIOGENESIS; ANIMAL; BLOOD FLOW; CAPILLARY; CYTOLOGY; EXERCISE; EXTRACELLULAR MATRIX; GROWTH, DEVELOPMENT AND AGING; HUMAN; MUSCLE CELL; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CAPILLARIES; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; EXERCISE; EXTRACELLULAR MATRIX; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MATRIX METALLOPROTEINASES; MUSCLE FIBERS; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; REGIONAL BLOOD FLOW; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036782748     PISSN: 10667814     EISSN: None     Source Type: Journal    
DOI: 10.1139/h02-027     Document Type: Article

References (142)

1. Adair, T.H., Gay, W.J., and Montani, J.P. (1990). Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am. J Physiol. 259: R393-R404.
2. Adair, T.H., Montani, J.P., Strick, D.M., and Guyton, A.C. (1989). Vascular development in chick embryos: a possible role for adenosine. Am. J. Physiol. 256: H240-H246.
3. Akai, Y., Homma, T., Burns, K.D., Yasuda, T., Badr, K.F., and Harris, R.C. (1994). Mechanical stretch/relaxation of cultured rat mesangial cells induces protooncogenes and cyclooxygenase. Am. J. Physiol. 267: C482-C490.
4. Amaral, S.L., Linderman, J.R., Morse, M.M., and Greene, A.S. (2001). Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF. Microcirculation 8: 57-67.
5. Armstrong, R.B., and Laughlin, M.H. (1983). Blood flows within and among rat muscles as a function of time during high speed treadmill exercise. J. Physiol. 344: 189-208.
6. Atkinson, S.J., Patterson, M.L., Butler, M.J., and Murphy, G. (2001). Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell model. FEBS Lett. 491: 222-226.
7. Ausprunk, D., and Folkman, J. (1977). Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 14: 53-65.
8. Bassiouny, H.S., Song, R.H., Hong, X.F., Singh, A., Kocharyan, H., and Glagov, S. (1998). Flow regulation of 72-kD collagenase IV (MMP-2) after experimental arterial injury. Circulation 98: 157-163.
9. Behnke, B.J., Kindig, C.A., Musch, T.I., Koga, S., and Poole, D.C. (2001). Dynamics of microvascular oxygen pressure across the rest-exercise transition in rat skeletal muscle. Respir. Physiol. 126: 53-63.
10. Bein, K., and Simons, M. (2000). Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity. J. Biol. Chem. 275: 32167-32173.
11. Benoit, H., Jordan, M., Wagner, H., and Wagner, P.D. (1999). Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression. J. Appl. Physiol. 86: 1513-1518.
12. Bergers, G., Brekken, R., McMahon, G., Vu, T.H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., and Hanahan, D. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2: 737-744.
13. Bigard, A.X., Brunet, A., Guezennec, C.Y., and Monod, H. (1991). Effects of chronic hypoxia and endurance training on muscle capillarity in rats. Pflugers Arch. 419: 225-229.
14. Bornstein, P. (2000). Matricellular proteins: an overview. Matrix Biol. 19: 555-556.
15. Breen, E.C., Johnson, E.C., Wagner, H., Tseng, H.-M., Sung, L.A., and Wagner, P.D. (1996). Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J. Appl. Physiol. 81: 355-361.
16. Brown, M.D., Walter, H., Hansen-Smith, F.M., Hudlicka, O., and Egginton, S. (1998). Lack of involvement of basic fibroblast growth factor (FGF-2) in capillary growth in skeletal muscle exposed to long-term contractile activity. Angiogenesis 2: 81-91.
17. Burton, H.W., and Barclay, J.K. (1986). Metabolic factors from exercising muscle and the proliferation of endothelial cells. Med. Sci. Sports Exerc. 18: 390-395.
18. Canfield, A.E., and Schor, A.M. (1995). Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J. Cell Sci. 108: 797-809.
19. Carmeliet, P. (2000). VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat. Med. 6: 1102-1103.
20. Chen, H., Herndon, M.E., and Lawler, J. (2000). The cell biology of thrombospondin-1. Matrix Biol. 19: 597-614.
21. Chen, K.D., Li, Y.S., Kim, M., Li, S., Yuan, S., Chien, S., and Shyy, J.Y. (1999). Mechanotransduction in response to shear stress. Roles of receptor tyrosine kinases, integrins, and Shc. J. Biol. Chem. 274: 18393-18400.
22. Chen, W.T., and Wang, J.Y. (1999). Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization. Ann. N. Y. Acad. Sci. 878: 361-371.
23. Chicurel, M.E., Chen, C.S., and Ingber, D.E. (1998). Cellular control lies in the balance of forces. Current Op. Cell Biol. 10: 232-239.
24. Chua, C.C., Hamdy, R.C., and Chua, B.H. (2000). Mechanism of transforming growth factor-betal-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells. Biochim. Biophys. Acta. 1497: 69-76.
25. Clark, D.R., and Smith, P. (1978). Capillary density and muscle fibre size in the hearts of rats subjected to stimulated high altitude. Cardiovasc. Res. 12: 578-584.
26. Colorado P.C., Torre, A., Kamphaus, G., Maeshima, Y., Hopfer, H., Takahashi, K., Volk, R., Zamborsky, E.D., Herman, S., Sarkar, P.K., Ericksen, M.B., Dhanabal, M., Simons, M., Post M., Kufe, D.W., Weichselbaum, R.R., Sukhatme, V.P., and Kallun, R. (2000). Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res. 60: 2520-2526.
27. Davis, G.E., Black, S.M., and Bayless, K.J. (2000). Capillary morphogenesis during human endothelial cell invasion of three-dimensional collagen matrices. In Vitro Cell Dev. Biol. Anim. 36: 513-519.
28. Dawson, J.M., and Hudlicka, O. (1989). The effects of long term administration of prazosin on the microcirculation in skeletal muscles. Cardiovasc. Res. 23: 913-920.
29. Dawson, J.M., and Hudlicka, O. (1993). Can changes in microcirculation explain capillary growth in skeletal muscle? Int. J. Exp. Pathol. 74: 65-71.
30. Dusseau, J.W. and Hutchins, P.M. (1988). Hypoxia-induced angiogenesis in chick chorioallantoic membranes: a role for adenosine. Respir. Physiol. 71: 33-44.
31. Egginton, S., Hudlicka, O., Brown, M.D., Walter, H., Weiss, J.B., and Bate A. (1998). Capillary growth in relation to blood flow and performance in overloaded rat skeletal muscle. J. Appl. Physiol. 85: 2025-2032.
32. Egginton, S., Zhou, A.L., Brown, M.D., and Hudlicka, O. (2001). Unorthodox angiogenesis in skeletal muscle. Cardiovasc. Res. 49: 634-646.
33. Ellerbroek, S.M., Wu, Y.I., Overall, C.M., and Stack, M.S. (2001). Functional Interplay between Type I Collagen and Cell Surface Matrix Metalloproteinase Activity. J. Biol. Chem. 276: 24833-24842.
34. Ethier, M.F., and Dobson, J.G., Jr. (1997). Adenosine stimulation of DNA synthesis in human endothelial cells. Am. J. Physiol. 272: H1470-H1479.
35. Foda, H.D., George, S., Conner, C., Drews, M., Tompkin, D.C., and Zucker, S. (1996). Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate (PMA): A protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. Lab. Invest. 74: 538-545.
36. Friedlander, M., Brooks, P.C., Shaffer, R.W., Kincaid, C.M., Varner, J.A., and Cheresh, D.A. (1995). Definition of two angiogenic pathways by distinct alpha v integrins. Science 270: 1500-1502.
37. Fulgenzi, G., Graciotti, L., Collis, M.G., and Hudlicka, O. (1998). The effect of alpha 1 adrenoceptor antagonist prazosin on capillary supply, blood flow and performance in a rat model of chronic muscle ischaemia. Eur. J Vasc. Endovasc. Surg. 16: 71-77.
38. Gavin, T.P., Spector, D.A., Wagner, H., Breen, E.C., and Wagner, P.D. (2000). Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise. J. Appl. Physiol. 88: 1192-1198.
39. Gerber, H.P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B.A., Dixit, V., and Ferrara, N. (1998). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273: 30336-30343.
40. Grant, M.B., Tarnuzzer, R.W., Caballero, S., Ozeck, M.J., Davis, M.I., Spoerri, P.E., Feoktistov, I., Biaggioni, I., Shryock, J.C., and Belardinelli, L. (1999). Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res. 85: 699-706.
41. Gu, J.W., Brady, A.L., Anand, V., Moore, M.C., Kelly, W.C., and Adair, T.H. (1999). Adenosine upregulates VEGF expression in cultured myocardial vascular smooth muscle cells. Am. J. Physiol. 277: H595-H602.
42. Gu, J.W., Ito, B.R., Sartin, A., Frascogna, N., Moore, M., and Adair, T.H. (2000). Inhibition of adenosine kinase induces expression of VEGF mRNA and protein in myocardial myoblasts. Am. J Physiol Heart Circ. Physiol. 279: H2116-H2123.
43. Gustafsson, T., Puntschart, A., Kaijser, L., Jansson, E., and Sundberg, C.J. (1999). Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am. J Physiol. 276: H679-H685.
44. Haas, T.L., Davis, S.J., and Madri, J.A. (1998). Three dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J. Biol. Chem. 273: 3604-3610.
45. Haas, T.L., and Madri, J.A. (1999). Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: Implications for angiogenesis. Trends Cardiovasc. Med. 9: 70-77.
46. Haas, T.L., Milkiewicz, M., Davis, S.J., Zhou, A.L., Egginton, S., Brown, M.D., Madri, J.A., and Hudlicka, O. (2000). Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. Am. J. Physiol Heart Circ Physiol. 279: H1540-H1547.
47. Haas, T.L., Stitelman, D., Davis, S.J., Apte, S.S., and Madri, J.A. (1999). Egr-1 mediates 1 extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium. J. Biol. Chem. 274: 22679-22685.
48. Hang, J., Kong, L., Gu, J.W., and Adair, T.H. (1995). VEGF gene expression is upregulated in electrically stimulated rat skeletal muscle. Am. J. Physiol. 269: H1827-H1831.
49. Harik, S.I., Hritz, M.A., and LaManna, J.C. (1995). Hypoxia-induced brain angiogenesis in the adult rat. J. Physiol. 485(Pt 2): 525-530.
50. Hirai, Y., Migita, K., Honda, S., Ueki, Y., Yamasaki, S., Urayama, S., Kamachi, M., Kawakami, A., Ida, H., Kita, M., Fukuda, T., Shibatomi, K., Kawabe, Y., Aoyagi, T., and Eguchi, K. (2001). Effects of nitric oxide on matrix metalloproteinase-2 production by rheumatoid synovial cells. Life Sci. 68: 913-920.
51. Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S.A., Mankani, M., Robey, P.G., Poole, A.R., Pidoux, I., Ward, J.M., and Birkedal-Hansen, H. (1999). MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81-92.
52. Houston, P., Campbell, C.J., Svaren, J., Milbrandt, J., and Braddock, M. (2001). The transcriptional corepressor NAB2 blocks Egr-1-mediated growth factor activation and angiogenesis. Biochem. Biophys. Res. Commun. 283: 480-486.
53. Hudlicka, O. (1998). Is physiological angiogenesis in skeletal muscle regulated by changes in microcirculation? Microcirculation 5: 7-23.
54. Hudlicka, O., Brown, M.D., and Egginton, S. (1992). Angiogenesis in skeletal and cardiac muscle. Physiol. Rev. 72: 369-417.
55. Hudlicka, O., Brown, M.D., and Silgram, H. (2000). Inhibition of capillary growth in chronically stimulated rat muscles by N(G)-nitro-1-arginine, nitric oxide synthase inhibitor. Microvasc. Res. 59: 45-51.
56. Hynes, R.O. (1992). Integrins: Versatility, modulation and signaling in cell adhesion. Cell 69: 11-25.
57. Ikuta, T., Ariga, H., and Matsumoto, K. (2000). Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation. Genes Cells 5: 913-927.
58. Ilan, N., Mahooti, S., and Madri, J.A. (1998). Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J. Cell Sci. 111(Pt 24): 3621-3631.
59. Ingber, D.E. (1997). Tensegrity: the architectural basis of cellular mechanotransduction. Annu. Rev. Physiol. 59: 575-599.
60. Itoh, T., Ikeda, T., Gomi, H., Nakao, S., Suzuki, T., and Itohara, S. (1997). Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem. 272: 22389-22392.
61. Jackson, C.J., and Nguyen, M. (1997). Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. Int. J Biochem. Cell Biol. 29: 1167-1177.
62. James, N.T. (1981). A stereological analysis of capillaries in normal and hypertrophic muscle. J. Morphol. 168: 43-49.
63. Jensen, J.A., Hunt, T.K., Scheuenstuhl, H., and Banda, M.J. (1986). Effect of lactate, pyruvate, and pH on secretion of angiogenesis and mitogenesis factors by macrophages. Lab Invest 54: 574-578.
64. Jiang, B.H., Semenza, G.L., Bauer, C., and Marti, H.H. (1996). Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am. J Physiol. 271: C1172-C1180.
65. Kayar, S.R., and Banchero, N. (1985). Myocardial capillarity in acclimation to hypoxia. Pflugers Arch. 404: 319-325.
66. Kelley, G. (1996). Mechanical overload and skeletal muscle fiber hyperplasia: a metaanalysis. J. Appl. Physiol. 81: 1584-1588.
67. Kelly, J.J., Moore, T.M., Babal, P., Diwan, A.H., Stevens, T., and Thompson, W.J. (1998). Pulmonary microvascular and macrovascular endothelial cells: differential regulation of Ca2+ and permeability. Am. J Physiol. 274: L810-L819.
68. Khachigian, L.M., Lindner, V., Williams, A.J., and Collins, T. (1996). Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 271: 1427-1431.
69. Klagsbrun, M. (1991). Regulators of angiogenesis: stimulators, inhibitors, and extracellular matrix. J. Cell Biochem. 47: 199-200.
70. Ladoux, A., and Frelin, C. (1993). Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem. Biophys. Res. Commun. 195: 1005-1010.
71. LaManna, J.C., Vendel, L.M., and Farrell, R.M. (1992). Brain adaptation to chronic hypobaric hypoxia in rats. J. Appl. Physiol. 72: 2238-2243.
72. Lamoreaux, W.J., Fitzgerald, M.E., Reiner, A., Hasty, K.A., and Charles, S.T. (1998). Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc. Res. 55: 29-42.
73. Lane, T.F., Iruela-Arispe, M.L., Johnson, R.S., and Sage, E.H. (1994). SPARC is a source of copper-binding peptides that stimulate angiogenesis. J. Cell Biol. 125: 929-943.
74. Lane, T.F., Iruela-Arispe, M.L., and Sage, E.H. (1992). Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1. J. Biol. Chem. 267: 16736-16745.
75. Lewalle, J.M., Munaut, C., Pichot, B., Cataldo, E., Baramova, E., and Foidart, J.M. (1995). Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells. J. Cell. Physiol. 165: 475-483.
76. Li, J., Hampton, T., Morgan, J.P., and Simons, M. (1997). Stretch-induced VEGF expression in the heart. J. Clin. Invest. 100: 18-24.
77. Liu, L., Tsai, J.C., and Aird, W.C. (2000). Egr-1 gene is induced by the systemic administration of the vascular endothelial growth factor and the epidermal growth factor. Blood 96: 1772-1781.
78. Madri, J.A., and Pratt, B.M. (1986). Endothelial Cell-Matrix Interactions: In Vitro Models of Angiogenesis. J. Histochem. Cytochem. 34: 85-91.
79. Massova, I., Kotra, L.P., Fridman, R., and Mobashery, S. (1998). Matrix metalloproteinases: structures, evolution, and diversification. FASEB J. 12: 1075-1095.
80. Meininger, C.J., and Granger, H.J. (1990). Mechanisms leading to adenosine-stimulated proliferation of microvascular endothelial cells. Am. J. Physiol. 258: H198-H206.
81. Meininger, C.J., Schelling, M.E., and Granger, H.J. (1988). Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am. J Physiol. 255: H554-H562.
82. Ment, L.R., Stewart, W.B., Fronc, R., Seashore, C., Mahooti, S., Scaramuzzino, D., and Madri, J.A. (1997). Vascular endothelial growth factor mediates reactive angiogenesis in the postnatal developing brain. Brain Res Dev. Brain Res. 100: 52-61.
83. Mertens, P.R., Alfonso-Jaume, M.A., Steinmann, K., and Lovett, D.H. (1998). A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J. Biol. Chem. 273: 32957-32965.
84. Merwin, J.R., Anderson, J.M., Kocher, O., Itallie, C.M.V., and Madri, J.A. (1990). Transforming growth factor beta modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J. Cell Physiol. 142: 117-128.
85. Meyer, C.J., Alenghat, F.J., Rim, P., Fong, J.H., Fabry, B., and Ingber, D.E. (2000). Mechanical control of cyclic AMP signalling and gene transcription through integrins. Nat. Cell Biol. 2: 666-668.
86. Michel, J.B., Ordway, G.A., Richardson, J.A., and Williams, R.S. (1994). Biphasic induction of immediate early gene expression accompanies activity-dependent angiogenesis and myofiber remodeling of rabbit skeletal muscle. J. Clin. Invest. 94: 277-285.
87. Milkiewicz, M., Brown, M., Egginton, S., and Hudlicka, O. (2001). Association between shear stress, angiogenesis and VEGF in skeletal muscles in vivo. Microcirculation 8:229-241.
88. Milkiewicz, M., Hudlicka, O., and Brown, M. (2000). Hypoxia as a stimulus for vascular endothelial growth factor expression and capillary growth in rat and rabbit skeletal muscle during chronic stimulation. J. Physiol. 523: 147P-148P.
89. Moses, M.A. (1997). The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells 15:180-189.
90. Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, J.F., Fishman, M.C., Huang, P.L., and Isner, J.M. (1998). Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101: 2567-2578.
91. Murphy, G., Knauper, V., Cowell, S., Hembry, R., Stanton, H., Butler, G., Freije, J., Pendas, A.M., and Lopez-Otin, C. (1999). Evaluation of some newer matrix metalloproteinases. Ann. N. Y. Acad. Sci. 878: 25-39.
92. Nagase, H. (1998). Cell surface activation of progelatinase A (proMMP-2) and cell migration. Cell Research 8: 179-186.
93. Nicosia, R.F., and Madri, J.A. (1987). The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model. Am. J Pathol. 128: 78-90.
94. Olfert, I.M., Breen, B.C., Mathieu-Costello, O., and Wagner, P.D. (2001). Chronic hypoxia attenuates resting and exercise-induced VEGF, flt-1, and flk-1 mRNA levels in skeletal muscle. J. Appl. Physiol. 90: 1532-1538.
95. Osol, G. (1995). Mechanotransduction by vascular smooth muscle. J. Vasc. Res. 32: 275-292.
96. Paku, S., and Paweletz, N. (1991). First steps of tumor-related angiogenesis. Lab. Invest. 65: 334-346.
97. Papapetropoulos, A., Garcia-Cardena, G., Madri, J.A., and Sessa, W.C. (1997). Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest 100: 3131-3139.
98. Pepper, M.S. (1997). Manipulating angiogenesis. From basic science to the bedside. Arterioscler. Thromb. Vasc. Biol. 17: 605-619.
99. Pepper, M.S. (2001). Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21: 1104-1117.
100. Petitclerc, E., Boutaud, A., Prestayko, A., Xu, J., Sado, Y., Ninomiya, Y., Sarras, M.P., Jr., Hudson, B.G., and Brooks, P.C. (2000). New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J. Biol. Chem. 275: 8051-8061.
101. Petrova, T.V., Makinen, T., and Alitalo, K. (1999). Signaling via vascular endothelial growth factor receptors. Exp. Cell Res. 253: 117-130.
102. Pozzi, A., Wary, K.K., Giancotti, F.G., and Gardner, H.A. (1998). Integrin alpha1beta1 mediates a unique collagen-dependent proliferation pathway in vivo. J. Cell Biol. 142: 587-594.
103. Puyraimond, A., Fridman, R., Lemesle, M., Arbeille, B., and Menashi, S. (2001). MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp. Cell Res. 262: 28-36.
104. Richardson, R.S., Noyszewski, E.A., Kendrick, K.F., Leigh, J.S., and Wagner, P.D. (1995). Myoglobin O2 desaturation during exercise. Evidence of limited O2 transport. J. Clin. Invest. 96: 1916-1926.
105. Richardson, R.S., Wagner, H., Mudaliar, S.R., Henry, R., Noyszewski, E.A., and Wagner, P.D. (1999). Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise. Am. J. Physiol. 277: H2247-H2252.
106. Rivilis, I., Milkiewecz, M., Boyd, P., Goldstein, J., Brown, M.D., Egginton, S., Hansen, F.M., Hudlicka, O., and Haas, T.L. (2002). Differential involvement of MMP-2 and VEGF during muscle stretch-versus shear stress-induced angiogenesis. Am. J. Physiol. 283: H1430-H1438.
107. Roca, J., Gavin, T.P., Jordan, M., Siafakas, N., Wagner, H., Benoit, H., Breen, E., and Wagner, P.D. (1998). Angiogenic growth factor mRNA responses to passive and contractioninduced hyperperfusion in skeletal muscle. J. Appl. Physiol. 85: 1142-1149.
108. Saadeh, P.B., Mehrara, B.J., Steinbrech, D.S., Dudziak, M.E., Greenwald, J.A., Luchs, J.S., Spector, J.A., Ueno, H., Gittes, G.K., and Longaker, M.T. (1999). Transforming growth factor-beta1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am. J Physiol. 277: C628-C637.
109. Sato, H., Okada, Y., and Seiki, M. (1997). Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Thrombosis Haemostasis 78: 497-500.
110. Schoefl, G.I. (1963). Studies on inflammation.III. Growing capillaries: their structure and permeability. Virchows Arch. A. 97-141.
111. Schwachtgen, J.L., Houston, P., Campbell, C., Sukhatme, V., and Braddock, M. (1998). Fluid shear stress activation of egr-1 transcription in cultured human endothelial and epithelial cells is mediated via the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway. J. Clin. Invest. 101: 2540-2549.
112. Seltzer, J.L., Lee, A.Y., Akers, K.T., Sudbeck, B., Southon, E.A., Wayner, E.A., and Eisen, A.Z. (1994). Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp. Cell Res. 213: 365-374.
113. Semenza, G.L. (2001). HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13: 167-171.
114. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845.
115. Sillau, A.H., Aquin, L., Bui, M.V., and Banchero, N. (1980). Chronic hypoxia does not affect guinea pig skeletal muscle capillarity. Pflugers Arch. 386: 39-45.
116. Silverman, E.S., and Collins, T. (1999). Pathways of Egr-1-mediated gene transcription in vascular biology. Am. J. Pathol. 154: 665-670.
117. Snyder, G.K., Byers, R.L., and Kayar, S.R. (1984). Effects of hypoxia on tissue capillarity in geese. Respir. Physiol. 58: 151-160.
118. Snyder, G.K., Farrelly, C., and Coelho, J.R. (1992). Adaptations in skeletal muscle capillarity following changes in oxygen supply and changes in oxygen demands. Eur. J. Appl. Physiol Occup. Physiol. 65: 158-163.
119. Snyder, G.K., Wilcox, E.E., and Burnham, E.W. (1985). Effects of hypoxia on muscle capillarity in rats. Respir. Physiol. 62: 135-140.
120. Spector, J.A., Mehrara, B.J., Greenwald, J.A., Saadeh, P.B., Steinbrech, D.S., Bouletreau, P.J., Smith, L.P., and Longaker, M.T. (2001). Osteoblast expression of vascular endothelial growth factor is modulated by the extracellular microenvironment. Am. J Physiol Cell Physiol. 280: C72-C80.
121. Stetler-Stevenson, W.G. (1999). Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest. 103: 1237-1241.
122. Strick, D.M., Waycaster, R.L., Montani, J.P., Gay, W.J., and Adair, T.H. (1991). Morphometric measurements of chorioallantoic membrane vascularity: effects of hypoxia and hyperoxia. Am. J. Physiol. 260: H1385-H1389.
123. Suarez, J., and Rubio, R. (1991). Regulation of glycolytic flux by coronary flow in guinea pig heart. Role of vascular endothelial cell glycocalyx. Am. J. Physiol. 261: H1994-H2000.
124. Takagi, H., King, G.L., Robinson, G.S., Ferrara, N., and Aiello, L.P. (1996). Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol. Vis. Sci. 37: 2165-2176.
125. Taraboletti, G., Morbidelli, L., Donnini, S., Parenti, A., Granger, H.J., Giavazzi, R., and Ziche, M. (2000). The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells. FASEB J. 14: 1674-1676.
126. Traub, O., and Berk, B.C. (1998). Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler. Thromb. Vasc. Biol. 18: 677-685.
127. Tronc, F., Mallat, Z., Lehoux, S., Wassef, M., Esposito, B., and Tedgui, A. (2000). Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler. Thromb. Vasc. Biol. 20: E120-E126.
128. Unemori, E.N., Ferrara, N., Bauer, E.A., and Amento, E.P. (1992). Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol. 153: 557-562.
129. Vernon, R.B., and Sage, E.H. (1995). Between molecules and morphology. Extracellular matrix and creation of vascular form. Am. J. Path. 147: 873-883.
130. Vogel, W. (1999). Discoidin domain receptors: Structural relations and functional implications. FASEB J. 13 Suppl: S77-S82.
131. Vogt M., Puntschart, A., Geiser, J., Zuleger, C., Billeter, R., and Hoppeler, H. (2001). Molecular adaptations in human skeletal muscle to endurance training under simulated hypoxic conditions. J. Appl. Physiol. 91: 173-182.
132. Wang, H., and Keiser, J.A. (1998). Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ Res. 83: 832-840.
133. Werb, Z., Tremble, P.M., Behrendtsen, O., Crowley, E., and Damsky, C.H. (1989). Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell Biol. 109: 877-889.
134. Westermarck, J., and Kahari, V.M. (1999). Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13: 781-792.
135. Yang, Z., Kyriakides, T.R., and Bornstein, P. (2000). Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol. Biol. Cell. 11: 3353-3364.
136. Yashima, R., Abe, M., Tanaka, K., Ueno, H., Shitara, K., Takenoshita, S., and Sato, Y. (2001). Heterogeneity of the signal transduction pathways for VEGF-induced MAPKs activation in human vascular endothelial cells. J Cell Physiol. 188: 201-210.
137. Yue, X., and Tomanek, R.J. (1999). Stimulation of coronary vasculogenesis/angiogenesis by hypoxia in cultured embryonic hearts. Dev. Dyn. 216:28-36.
138. Zachary, I. (2001). Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am. J Physiol Cell Physiol. 280: C1375-C1386.
139. Zagzag, D., Friedlander, D.R., Dosik, J., Chikramane, S., Chan, W., Greco, M.A., Allen, J.C., Dorovini-Zis, K., and Grumet, M. (1996). Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res. 56: 182-189.
140. Zheng, W., Brown, M.D., Brock, T.A., Bjercke, R.J., and Tomanek, R.J. (1999). Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ. Res. 85: 192-198.
141. Zhou, Z., Apte, S.S., Soininen, R., Cao, R., Baaklini, G.Y., Rauser, R.W., Wang, J., Cao, Y., and Tryggvason, K. (2000). Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. U.S.A. 97: 4052-4057.
142. Ziada, A.M., Hudlicka, O., Tyler, K.R., and Wright, A.J. (1984). The effect of long-term vasodilatation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc. Res. 18: 724-732.